SCHEMBL25913399

SCHEMBL25913399

Cc1ncc(-c2ccc3cc(Oc4ccnc(Br)c4)ccc3n2)c(=O)n1C

nearest known ligand 0.39

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ CSF1R P07333 11/20 0.39
▸ PDGFRA P16234 6/20 0.39
▸ FLT3 P36888 4/20 0.39
▸ PDGFRB P09619 2/20 0.39
▸ LCK P06239 1/20 0.39
▸ KIT P10721 1/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ PTK6 Q13882 1/20 0.39
▸ BRAF P15056 4/20 0.33
▸ KDR P35968 2/20 0.33
▸ RAF1 P04049 2/20 0.33
▸ MAOB P27338 2/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ ALDH1A1 P00352 1/20 0.32
▸ HTT P42858 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ NOD2 Q9HC29 1/20 0.32
▸ SCN9A Q15858 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL25914740 0.87 CSF1R (0.35) CSF1RPDGFRAFLT3PDGFRBLCK
SCHEMBL25911790 0.85 CSF1R (0.53) CSF1RPDGFRAFLT3PDGFRBLCK
SCHEMBL25910556 0.83 PDGFRB (0.49) CSF1RPDGFRAFLT3PDGFRBLCK
SCHEMBL25914665 0.82 CSF1R (0.39) CSF1RPDGFRAFLT3PDGFRBLCK
SCHEMBL25913387 0.82 KCNH2 (0.35) —
SCHEMBL25912706 0.81 CSF1R (0.43) CSF1RPDGFRAFLT3PDGFRBLCK
SCHEMBL25914529 0.81 GAA (0.41) CSF1RPDGFRAFLT3PDGFRBLCK
SCHEMBL25913446 0.80 MAOA (0.35) BRAFRAF1MAOBMEN1ALDH1A1
SCHEMBL25913040 0.77 KDM4E (0.38) BRAFALDH1A1SCN9A
SCHEMBL25913396 0.76 ESR2 (0.46) PDGFRAPDGFRBMEN1ALDH1A1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023125812-A1 SUBSTITUTED PYRIMIDONE DERIVATIVE, AND PHARMACEUTICAL COMPOSITION AND MEDICAL USE THEREOF 上海海雁医药科技有限公司 2023-07-06 — — WO disclosed
Send feedback